Professional Documents
Culture Documents
Outcomes of late
onset Candida sepsis
I nvestigators of the Eunice Kennedy Shriver National Institute of Child Health and
Human Development Neonatal Research Network, enrolled 1515 infants with
extremely low birth weight (ELBW; <1000 g) and suspected sepsis to investigate
in extremely low birth the relative importance of etiologic agent of sepsis on outcome. Ninety percent of
enrolled infants (1317/1515) were examined for neurodevelopmental outcome at 18
weight infants months of age. Investigators were able to compare outcomes for those suspected of
Sarah S. Long, MD sepsis who had proven Candida infection versus proven bacterial infection versus
no proven infection, as well as perform a post hoc comparison with a cohort of 864
ELBW infants concurrently enrolled in the registry who were not suspected of late
onset sepsis (LOS).
Neurodevelopmental impairment was found in 31% of ELBW infants with Candida
and 31% with non-Candida LOS and/or meningitis. Compared with infants in the
registry who had never been screened for sepsis, those with Candida infection were
more likely to have neurodevelopmental impairment (OR 1.83, 95% CI 1.01. 3.33
and P = .047). Dramatically increased mortality and disability following Candida
sepsis was apparent in infants with birth weight <750 grams50% mortality and
33% of survivors having neurodevelopmental impairment.
This study helps rectify discrepant findings in studies without the current
studys clear comparison groups. It also urges a better understanding of Candida
disease and prevention to optimize outcomes for this exquisitely vulnerable
population.
Article page 680<
613
Predicting outcome I n this issue of The Journal, investigators from Spain report the use of clinical,
biochemical, and neuroimaging findings in the neonatal period in infants
of symptomatic with congenital cytomegalovirus (CMV) infection to predict long-term neurode-
CMV infection velopmental outcome. The strengths of the study are the performance of multiple
biochemical tests on the neonates cerebrospinal fluid (ie, neuron-specific enolase
Sarah S. Long, MD and b2-microglobulin, the latter of which is thought to be a reflection of local cell
turnover), neuroimaging studies, long-term follow-up to an average age of 8.7
years (range 19 months to 18 years), and extensive neurodevelopmental testing
(eg, cognitive, behavioral, motor, visual, auditory). Results show that adjusted
head circumference 2 SD below expected, cerebrospinal fluid b2-microglobulin
of $ 8 mg/L, or moderate to severe neuroimaging abnormalities, individually
and especially when combined, have excellent predictive value for moderate-
severe disability. These findings will not only aid clinicians but will better inform
clinical trials of potential therapies.
Article page 828<
Chorioamnionitis and
neurodevelopment
T he association between clinical and/or histological chorioamnionitis and poor neu-
rodevelopmental outcomes or death in newborns has been debated, with multiple
positive and negative studies in the literature. This association for preterm birth
Alan H. Jobe, MD, PhD perhaps is even more controversial. As more is learned about the types of infections
that are associated with premature delivery, any interpretation of an outcome relative
to a simple diagnosis of chorioamnionitis is inadequate. Some pregnancies are compli-
cated by chronic and indolent infections with single or multiple organisms not nor-
mally considered to be pathogenic, and others result in preterm deliveries with clear
pathogens. Inflammation-associated preterm labor may be primarily from the endo-
metrium and minimally involve the fetus, or the fetus may mount a systemic inflam-
matory response.
In this issue of The Journal, Salas et al carefully characterized and graded cord
inflammation to better identify the severity of the inflammation for a large number
of preterm deliveries. They report that a severe fetal inflammatory response was
associated with death or a poor neurodevelopmental outcome in preterm infants.
The logical association between fetal exposure to inflammation and brain injury be-
comes apparent with a better assessment of the inflammation. No doubt adverse
outcomes will associate with specific organisms, the duration of the fetal exposure,
and characteristics of the fetal and maternal inflammatory responses. Much more
needs to be learned about how to assess fetal risks to better direct the timing of
delivery.
Article page 652<
Association of asthma
and herpes zoster
T he incidence of asthma and herpes zoster (HZ) rose concurrently at the end of the
20th century. Investigators took advantage of the setting of Olmstead County,
Minnesota, where medical care is virtually self-contained, to perform a popula-
in children tion-based epidemiologic study to explore whether HZ was associated with asthma.
The study was performed before substantial use of varicella vaccine, and no case
Sarah S. Long, MD had received systemic corticosteroid in the three months prior to HZ. Twenty-three
percent of cases of HZ had asthma compared with 12.6% of matched controls
(aOR: 2.09, 95% CI 1.24-3.52; P = .006). The authors provide arguments about why
detection bias is likely not responsible for their finding. They conclude that asthma
may be an unrecognized risk factor for reactivation of nonairway-related latent
VZV infection and speculate that altered cell-mediated innate immune response could
be the biologic link.
Article page 816<